Re: It's Time For Zenith To Disclose

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: It's Time For Zenith To Disclose

in response to

Re: It's Time For Zenith To Disclose

BearDownAZ

posted on Jan 31, 2017 09:18PM

Per Sarah, no webcast for Resverlogix or Zenith at BIO CEO Investor conference in a couple of weeks.

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply